Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice.
Caccese M, Ferrara R, Pilotto S, Carbognin L, Grizzi G, Caliò A, Brunelli M, Cuppone F, Petraglia S, Scarpa A, Tortora G, Bria E. Caccese M, et al. Expert Opin Pharmacother. 2016 Dec;17(17):2253-2266. doi: 10.1080/14656566.2016.1242578. Epub 2016 Oct 8. Expert Opin Pharmacother. 2016. PMID: 27682212 Review.
Do immune checkpoint inhibitors need new studies methodology?
Ferrara R, Pilotto S, Caccese M, Grizzi G, Sperduti I, Giannarelli D, Milella M, Besse B, Tortora G, Bria E. Ferrara R, et al. Among authors: caccese m. J Thorac Dis. 2018 May;10(Suppl 13):S1564-S1580. doi: 10.21037/jtd.2018.01.131. J Thorac Dis. 2018. PMID: 29951307 Free PMC article. Review.
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer.
Pilotto S, Novello S, Peretti U, Kinspergher S, Ciuffreda L, Milella M, Carbognin L, Vavalà T, Ferrara R, Caccese M, Tortora G, Bria E. Pilotto S, et al. Among authors: caccese m. Expert Opin Investig Drugs. 2015;24(9):1143-61. doi: 10.1517/13543784.2015.1056341. Epub 2015 Jun 12. Expert Opin Investig Drugs. 2015. PMID: 26065529 Review.
Tubulin inhibitors in non-small cell lung cancer: looking back and forward.
Ferrara R, Pilotto S, Peretti U, Caccese M, Kinspergher S, Carbognin L, Karachaliou N, Rosell R, Tortora G, Bria E. Ferrara R, et al. Among authors: caccese m. Expert Opin Pharmacother. 2016 Jun;17(8):1113-29. doi: 10.1517/14656566.2016.1157581. Epub 2016 Mar 10. Expert Opin Pharmacother. 2016. PMID: 26898217 Review.
Quality of Life Perception, Cognitive Function, and Psychological Status in a Real-world Population of Glioblastoma Patients Treated With Radiotherapy and Temozolomide: A Single-center Prospective Study.
Lombardi G, Bergo E, Del Bianco P, Bellu L, Pambuku A, Caccese M, Trentin L, Zagonel V. Lombardi G, et al. Among authors: caccese m. Am J Clin Oncol. 2018 Dec;41(12):1263-1271. doi: 10.1097/COC.0000000000000459. Am J Clin Oncol. 2018. PMID: 29750673 Clinical Trial.
Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two cases.
Lombardi G, Caccese M, Bellu L, Pambuku A, Bergo E, Berti F, Gardiman MP, Della Puppa A, Denaro L, Dal Pos S, Zagonel V. Lombardi G, et al. Among authors: caccese m. Anticancer Drugs. 2018 Oct;29(9):924-928. doi: 10.1097/CAD.0000000000000678. Anticancer Drugs. 2018. PMID: 30080691
Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155).
Caccese M, Ceccato F, Fassan M, Fassina A, Padovan M, Mammi I, Iacobone M, Scaroni C, Zagonel V, Lombardi G. Caccese M, et al. Semin Oncol. 2019 Feb;46(1):104-105. doi: 10.1053/j.seminoncol.2018.12.005. Epub 2019 Jan 2. Semin Oncol. 2019. PMID: 30655020 No abstract available.
69 results